Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Researchers created a fully functional, bioengineered skin system with hair from stem cells that successfully integrated when transplanted into mice.

Fat-derived stem cells, platelet-rich plasma, and biomaterials show promise for healing chronic skin wounds and improving soft tissue with few side effects.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Researchers created hair-inducing human cell clusters using a 3D culture method.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Disrupting Acvr1b in mice causes severe hair loss and thicker skin.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

Massage increases how deep both rigid and flexible liposomes can go into skin, with flexible ones going deeper, and covering the skin (occlusion) helps rigid ones more.

Herbal extracts and platelet-rich plasma together may help increase hair growth by making certain cells grow more, through specific cell growth pathways.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

NSAIDs may not affect soft tissue healing but should be used carefully for bone fractures and more research is needed to understand sex differences in response.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Women with high androgen levels may have more severe COVID-19 symptoms.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Mobile phone radiation may cause DNA damage in human ear hair follicle cells.

CD10 and CD34 levels change during hair development and different hair growth stages, which could be important for hair regeneration treatments.